Tech Company Financing Transactions

Spotlight Therapeutics Funding Round

Epiq Capital, GordonMD Global Investments and Emerson Collective participated in a $36.5 million Series B funding round for Spotlight Therapeutics. This venture round was announced on 3/24/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

26118 Research Pl.
Hayward, CA 94545
USA

Phone

Undisclosed

Website

www.spotlighttx.com

Email Address

[email protected]

Overview

Despite the promise of permanence, the full therapeutic potential of CRISPR gene editing is hindered by current delivery methods. To address the multiple limitations of cell, viral- and nanoparticle-mediated delivery for gene editing, we are developing a new class of biologics called Targeted Active Gene Editors (TAGE).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mary Haak-Frendscho

        

Vice President

Mary Janatpour

        

Vice President

Hari Jayaram

        

Browse more venture capital transactions:

Prev: 3/24/2022: Virdee venture capital transaction
Next: 3/24/2022: Native Pet venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary